To support a randomized controlled trial evaluating the effectiveness of extended-release naltrexone on opioid relapse and recidivism in the New York City pre-release jail population.
New York University
2018 - 2022
Arnold Ventures funds projects to understand problems and identify policy solutions.
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.